These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 30287340)
1. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. Chen Y; Chen HN; Wang K; Zhang L; Huang Z; Liu J; Zhang Z; Luo M; Lei Y; Peng Y; Zhou ZG; Wei Y; Huang C J Hepatol; 2019 Jan; 70(1):66-77. PubMed ID: 30287340 [TBL] [Abstract][Full Text] [Related]
2. A novel role for ketoconazole in hepatocellular carcinoma treatment: linking PTGS2 to mitophagy machinery. Chen HN; Chen Y; Zhou ZG; Wei Y; Huang C Autophagy; 2019 Apr; 15(4):733-734. PubMed ID: 30653402 [TBL] [Abstract][Full Text] [Related]
3. Suppression of DRP1‑mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy. Ma M; Lin XH; Liu HH; Zhang R; Chen RX Oncol Rep; 2020 Mar; 43(3):1010-1018. PubMed ID: 32020220 [TBL] [Abstract][Full Text] [Related]
4. STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib. Zheng Y; Huang C; Lu L; Yu K; Zhao J; Chen M; Liu L; Sun Q; Lin Z; Zheng J; Chen J; Zhang J J Hematol Oncol; 2021 Jan; 14(1):16. PubMed ID: 33446239 [TBL] [Abstract][Full Text] [Related]
5. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Yao J; Wang J; Xu Y; Guo Q; Sun Y; Liu J; Li S; Guo Y; Wei L Autophagy; 2022 Aug; 18(8):1879-1897. PubMed ID: 34890308 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting Pink1/Parkin-mediated mitophagy enhances the anticancer effects of quercetin in hepatocellular carcinomaf. Chen F Biochem Biophys Res Commun; 2024 Jun; 712-713():149899. PubMed ID: 38653003 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551 [TBL] [Abstract][Full Text] [Related]
8. COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment. Dong XF; Liu TQ; Zhi XT; Zou J; Zhong JT; Li T; Mo XL; Zhou W; Guo WW; Liu X; Chen YY; Li MY; Zhong XG; Han YM; Wang ZH; Dong ZR Clin Cancer Res; 2018 Jul; 24(13):3204-3216. PubMed ID: 29514844 [No Abstract] [Full Text] [Related]
9. Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy. Zhou J; Feng J; Wu Y; Dai HQ; Zhu GZ; Chen PH; Wang LM; Lu G; Liao XW; Lu PZ; Su WJ; Hooi SC; Ye XP; Shen HM; Peng T; Lu GD Exp Mol Med; 2022 Nov; 54(11):2007-2021. PubMed ID: 36385558 [TBL] [Abstract][Full Text] [Related]
10. Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells. Wang J; Su Q; Wu Q; Chen K; Ullah A; Ghauri MA; Zhang Y Arch Pharm Res; 2021 Nov; 44(11):1025-1036. PubMed ID: 34751932 [TBL] [Abstract][Full Text] [Related]
11. Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma. Luo P; An Y; He J; Xing X; Zhang Q; Liu X; Chen Y; Yuan H; Chen J; Wong YK; Huang J; Gong Z; Du Q; Xiao W; Wang J Cancer Lett; 2024 Apr; 587():216621. PubMed ID: 38242198 [TBL] [Abstract][Full Text] [Related]
12. Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. Prieto-Domínguez N; Ordóñez R; Fernández A; Méndez-Blanco C; Baulies A; Garcia-Ruiz C; Fernández-Checa JC; Mauriz JL; González-Gallego J J Pineal Res; 2016 Oct; 61(3):396-407. PubMed ID: 27484637 [TBL] [Abstract][Full Text] [Related]
13. OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma. Zhao X; Tian C; Puszyk WM; Ogunwobi OO; Cao M; Wang T; Cabrera R; Nelson DR; Liu C Lab Invest; 2013 Jan; 93(1):8-19. PubMed ID: 23108376 [TBL] [Abstract][Full Text] [Related]
14. Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis. Wu H; Wang T; Liu Y; Li X; Xu S; Wu C; Zou H; Cao M; Jin G; Lang J; Wang B; Liu B; Luo X; Xu C J Exp Clin Cancer Res; 2020 Dec; 39(1):274. PubMed ID: 33280610 [TBL] [Abstract][Full Text] [Related]
15. MSCs ameliorate hepatocellular apoptosis mediated by PINK1-dependent mitophagy in liver ischemia/reperfusion injury through AMPKα activation. Zheng J; Chen L; Lu T; Zhang Y; Sui X; Li Y; Huang X; He L; Cai J; Zhou C; Liang J; Chen G; Yao J; Yang Y Cell Death Dis; 2020 Apr; 11(4):256. PubMed ID: 32312955 [TBL] [Abstract][Full Text] [Related]
16. Blocking Parkin/PINK1-mediated mitophagy sensitizes hepatocellular carcinoma cells to sanguinarine-induced mitochondrial apoptosis. Su Q; Wang J; Liu F; Zhang Y Toxicol In Vitro; 2020 Aug; 66():104840. PubMed ID: 32234456 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. Tong M; Che N; Zhou L; Luk ST; Kau PW; Chai S; Ngan ES; Lo CM; Man K; Ding J; Lee TK; Ma S J Hepatol; 2018 Oct; 69(4):826-839. PubMed ID: 29885413 [TBL] [Abstract][Full Text] [Related]
18. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993 [TBL] [Abstract][Full Text] [Related]
20. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma. Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]